Puas yog GLP-1 Patent Cliff Shifting Liraglutide Market Share?
Jun 24, 2026
Tso lus
Puas yog GLP-1 Patent Cliff Shifting Ntiaj Teb Liraglutide Kev Lag Luam?
Cov Pab Pawg Muag Khoom Yuav Ua Li Cas Los Ntawm Cov Txheej Txheem SPPS Peptide Supply Chains thiab Ua kom muaj kev tswj hwm kev ua raws cai?
Vim li cas Patent Cliff Tsav Tsheb Liraglutide Generic Procurement Boom?
Lub ntiaj teb cov kws tshuaj thiab cov kev tswj hwm kev lag luam siab tshaj plaws tau ntsib kev nthuav dav uas tsis tau pom dua los ntawmGLP-1 (Glucagon-zoo li Peptide-1) receptor agonists. Thaum cov xov xwm tseem ceeb tshaj tawm txog kev pom zoo ntawm cov neeg muaj koob npe thiab cov kev tswj hwm tus neeg siv khoom hnyav, qhov tseeb kev lag luam sib ntaus sib tua nyob sib sib zog nqus hauv B2B Active Pharmaceutical Ingredient (API) cov saw hlau.
Tam sim no, qhov tseem ceeb ntawm qhov kev hloov pauv no yog qhov yuav tshwm sim thiab pom tau tias "patent pob tsuas" ntawm Liraglutide. Tau ntau xyoo dhau los, cov tshuaj thawj zaug tau hais kom nyob ze -tag nrho kev ua lag luam sib koom, sib sau ua ke loj, ntev - cov ntaub ntawv soj ntsuam kev nyab xeeb. Qhov tseeb tiag niaj hnub no yog qhov tseem ceeb patents rau Liraglutide tau tas sij hawm los yog nyob rau hauv lub verge ntawm invalidation nyob rau hauv loj jurisdictions, nrog rau cov EU, Tuam Tshoj, thiab cov North American cheeb tsam.
Qhov patent tas sij hawm no tau ua rau muaj kev hloov pauv ntawm kev lag luam. Peb tab tom soj ntsuam ib qho kev nthuav dav hauv kev xav tau ntawm kev yuav khoomlag luam wholesale Liraglutide tejhmoov los ntawm generic kws manufacturers thiab chaw kho mob R & D. API tau nkag mus sai sai rau cov lag luam tawm tshiab, hais txog cov kev xav tau ntawm cov metabolic ntawm qhov loj, yav dhau los cov pej xeem tsis txaus ntseeg. Yog li ntawd, thawj B2B bottleneck tau hloov los ntawm kev ua lag luam tiam mus rau kev ruaj ntseg, kev lag luam - nplai ntau lawm.
Puas yog Broker Markups thiab Batch Inconsistency Sabotaging Koj Peptide Supply Chain?
Rau cov thawj coj ntawm kev yuav khoom, qhov kev thov loj hlob no tau nthuav tawm qhov tsis zoo hauv ntiaj teb peptide cov saw hlau. Kev ua lag luam tau nce zuj zus ntxiv nrog cov neeg ua haujlwm tsis tau lees paub thiab cov chaw soj ntsuam "kev tshawb fawb- qib" qis dua uas muab cov lus tsis txaus ntseeg tsawg. Cov pab pawg yuav khoom tab tom ntsib cov kab mob sib kis mob hnyav:
- Batch-rau-Batch Inconsistency:Tsawg-tier cov neeg muab khoom siv siv cov khoom siv roj crude-Phase Peptide Synthesis (SPPS) feem ntau ua tsis tiav thaum lub sij hawm ntsuas - nce. Ib qho piv txwv purity 99% feem ntau devolves rau hauv ib qho 85% bulk xa cov kab mob sib kis thiab cov kab mob amino acid uas tsis muaj kev cuam tshuam.
- Regulatory Document Deficiencies:Ntau lub tuam txhab lag luam tsis muaj peev xwm los muab cov ntaub ntawv pov thawj DMFs (Drug Master Files), ua tiav COAs, lossis cov ntaub ntawv khaws cia uas yuav tsum tau ua los ntawm FDA, EMA, lossis NMPA kev tshuaj xyuas.
- Hidden Circulation Nqis:Ntau -txheej txheej broker tes hauj lwm zais qhov feem pua ntawm cov khoom lag luam loj loj, ua rau R&D pob nyiaj siv thiab nce nqi kawg ntawm Cov Khoom Muag (COGS).
Yuav Ua Li Cas Cov Formulators Authenticate High -Purity Liraglutide API Powder?
Kev yuav khoom ntev -chain peptides tsis yog cov khoom lag luam; nws yog ib qho kev tawm dag zog hauv biochemical precision. Liraglutide yog ib qho nyuaj 31-amino acid polypeptide uas muaj qhov tseem ceeb 16-carbon palmitoyl fatty acid txuas rau lysine ntawm txoj hauj lwm 26. Synthesizing cov qauv no xav tau cov neeg tseem ceeb SPPS infrastructure thiab uncompromising purification raws tu qauv.
Qhov no yog vim li cas thoob ntiaj teb R & D cov koom haum thiab hwm cov tuam txhab ntxiv koom nrogXi'an Tihealth Biotechnology Co., Ltd.. Ua haujlwm raws li ISO9001: 2015 kev tswj xyuas kev ua tau zoo, peb tshem tawm qhov kev pheej hmoo ntawm tus broker los ntawm kev muab ncaj qha - los ntawm - Hoobkas, kev tshawb fawb APIs.
Tshawb xyuas Peb Cov Txheej Txheem GLP-1 Kev daws teeb meem:
- ➤ Liraglutide API hmoov (CAS 204656-20-2)- Engineered rau nruj soj ntsuam thiab coj mus muag scaling.
- ➤ Siab -Purity Liraglutide Peptide (CAS 204656-20-2)- Tau lees paub los ntawm HPLC/MS cross-kev pov thawj los lav qhov tseeb qhov tseeb thiab kev tshem tawm tsis huv.
Strategic Sourcing FAQ: GLP-1 Peptides
Cov pab pawg yuav khoom yuav tsum tau hloov ntawm qhov chaw tsis zoo- yuav mus ua kom tiav - cov ntawv cog lus ntev (Price-Lock Framework Orders). Lub tswv yim no ruaj ntseg muaj peev xwm tsim tau muaj peev xwm ua ntej, cuam tshuam cov nqi raws caij nyoog nyob rau hauv cov khoom siv amino acid, thiab lav cov khoom txuas ntxiv thaum muaj kev lag luam - thoob plaws GLP-1 tsis txaus.
Kev cia siab ib leeg ntawm kev pom TLC lossis HPLC theem pib tsis txaus rau kev txheeb xyuas cov qauv sib xyaw ua ke lossis cov khoom siv tshuaj tiv thaiv kab mob tsim tawm thaum lub sijhawm sib xyaw. Ntawm Xi'an Tihealth, peb tswj hwm High-Performance Liquid Chromatography ua ke nrog Mass Spectrometry (HPLC-MS) rau forensically cais thiab ua lej txheeb xyuas qhov hnyav molecular thiab purity profile ntawm txhua pawg.
Corporate Supply Chain Transparency
Lub generic GLP-1 kev ua lag luam tau nkag mus rau hauv kev ua raws li - lub sijhawm tsav. Xaiv cov khoom tsim nyog, cov ntaub ntawv- ua tiav, thiab ruaj khov- cov neeg muab khoom muaj peev xwm peptide yog txoj hauv kev rau R&D cov tuam tsev tswj hwm cov nqi sib tw thiab tuav cov txiaj ntsig zoo. Xi'an Tihealth pom nws tus kheej yog ib tus neeg ua lag luam kev sib koom tes ua lag luam-kev ua raws li qhov tseeb, ua kom muaj peev xwm API ntau lawm, thiab tsis muaj kev cuam tshuam tshuaj lom neeg.
* Kev Ua Raws Cai Tsis Txaus Siab: Cov khoom muaj kev tiv thaiv los ntawm patents siv tau yog nruj me ntsis rau R&D thiab kev soj ntsuam kuaj siv tsuas yog hauv cov cai txwv. Kev yuav khoom lag luam yog ua raws li txoj cai lij choj ntawm cov tswv cuab ntawm lub teb chaws kawg.*
Xa kev nug